1-4 of 4
Julie Warzecho, RN
Close
Sort by
Journal Articles

Pilot Study of Sorafenib for Myelodysplastic Syndrome

Arati Rao, MD, David A. Rizzieri, MD, Eduardo Vanegas, Joseph O. Moore, MD, Jon P. Gockerman, MD, Louis F. Diehl, MD, Donna Adams, RN, Julie Warzecho, RN, Carlos Decastro, MD
Journal: Blood
Blood (2012) 120 (21): 4948.
https://doi.org/10.1182/blood.V120.21.4948.4948
Published: 2012
Journal Articles

Phase 1 Study of Lenalidomide and Decitabine for High and Intermediate 2 Risk MDS

Arati Rao, MD, Ghazi Khan, David A. Rizzieri, MD, Joseph O. Moore, MD, Jon P. Gockerman, MD, Louis F. Diehl, MD, Anne W Beaven, MD, Donna Adams, RN, Julie Warzecho, RN, Carlos Decastro, MD
Journal: Blood
Blood (2012) 120 (21): 4935.
https://doi.org/10.1182/blood.V120.21.4935.4935
Published: 2012
Journal Articles

High Complete Response Rates with Dose Dense/Dose Intense Chemotherapy Plus Radioimmunotherapy in High Risk Diffuse Large B Cell and Mantle Cell Lymphoma

Anne W Beaven, MD, David A. Rizzieri, MD, Zachary Powell, Zhiguo Li, PhD, Peggy Alton, RN, Julie Warzecho, RN, Louis F. Diehl, MD, Joseph O. Moore, MD, Carlos Manuel de Castro, III, MD, Jon P. Gockerman, MD
Journal: Blood
Blood (2011) 118 (21): 2681.
https://doi.org/10.1182/blood.V118.21.2681.2681
Published: 2011
Journal Articles

A Phase I Study of the Combination of Decitabine with Lenalidomide for Patients with High Risk (IPSS Int-2 or High) Myelodysplastic Syndrome

Carlos Manuel de Castro, III, MD, Donna Adams, RN, Arati V Rao, MD, Joseph O. Moore, MD, Jon P. Gockerman, MD, Louis F. Diehl, MD, Anne W Beaven, MD, Julie Warzecho, RN, David A. Rizzieri, MD
Journal: Blood
Blood (2011) 118 (21): 5029.
https://doi.org/10.1182/blood.V118.21.5029.5029
Published: 2011